TrialBlood advances2022

Megadose 90Y-ibritumomab tiuxetan prior to allogeneic transplantation is effective for aggressive large B-cell lymphoma.

Victor A Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.